Schizophrenia. Schizophrenia, schizotypal and delusional disorders
Conditions
Interventions
Intervention 1: Actual excitation of 2 mA for 20 minutes and placement of the cathode electrode in the left DLPFC and anode in the patient's right Orbito Frontal. The intervention consists of 15 sessi
Sponsors
Zanjan University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: People diagnosed with schizophrenia on thebasis of DSM5 Patients receiving fixed antipsychotic treatment regimen for at least 4 weeks
Exclusion criteria
Exclusion criteria: 1-substance dependency comorbid psychiatric disorder(including suicidal individuals) neurologic diseases such as epilepcy,CVA or cerebral vessels disease physical disease such as malignancy,infections and heart failure, pragnancy, the existence of a metal implant in the body and skin disease involving scalp
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Positive and negative symptoms of schizophrenia. Timepoint: Pre-test, Post-test and follow up (one month after post-test). Method of measurement: Positive and Negative Syndrome Scale.;Negative Symptoms. Timepoint: Pre-test, Post-test and follow up (one month after post-test). Method of measurement: Scale for the Assessment of Negative Symptoms.;Depression. Timepoint: Pre-test, Post-test and follow up (one month after post-test). Method of measurement: Calgary Depression Scale for Schizophrenia. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactParya Jalili Khiavi
Zanjan University of Medical Sciences
Outcome results
None listed